|
XYA02 Clinical Trials
1 actively recruiting trial
Pipeline
Phase 1/2: 1
Top Sponsors
- XYone Therapeutics, Inc1
Indications
- MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors1
- GEJ Adenocarcinoma1
- Pancreatic Adenocarcinoma1
- Ovarian Cancer1
- Colorectal Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.